Prostate Cancer: less frequent prostate screening may be ok

Frequent screening for prostate cancer found more tumors overall, but failed to cut the number of aggressive tumors detected according to a study published in the Journal of the National Cancer Institute. This study further fuels the controversy over the value of screening tests for this cancer and how frequently such tests should be performed.

The researchers write that yearly PSA testing may lead to prostate cancer diagnoses that may be “clinically insignificant.” The American Cancer Society currently recommends doctors offer the PSA test or digital rectal exam, annually, to men starting at age 50. The goal is to catch the tumors early on when they are easiest to treat.

However, according to the lead author of this study, Monique Roobol, such frequent screening may also detect minor tumors that may pose no threat but end up receiving aggressive treatment.

Screening in Europe is generally less frequent than here in the U.S., roughly every four years at the institutions that took part in this study.

no comments for now | have your say »


  • Rash caused by Tarceva (and other EGFR inhibitors), a positive sign

    Development of a rash after treatment with inhibitors of epidermal growth factor receptor (EGFR) such as Tarceva (erlotinib) may actually indicate that the treatment is working well, according to an analysis of two phase III trials. According to the analysis, the worse the rash, the more likely patients are to ...

    September 2nd, 2007 | No comments yet

  • Self-collection of HPV testing specimens feasible

    In a new study published in CMAJ, Dr. Gina Oglivie and colleagues explored the feasibility of women self-collecting specimens for HPV testing. They focused on women who might not make full use of screening programs such as women who were homeless or involved in the sex trade. Nurses recruited women from ...

    August 31st, 2007 | No comments yet

  • Breast Cancer And Breast Density

    Studying the DNA of 889 people, gene hunters at the Mayo Clinic and H. Lee Moffitt Cancer Centers have identified a region on chromosome 5p that is significantly associated with dense breast tissue, a known risk factor for breast cancer. The findings, published in the September 1 issue of Cancer Research, ...

    August 31st, 2007 | No comments yet

  • Thyroid Cancer Survivors Conference

    Attention Thyroid cancer survivors and patients: the Thyroid Cancer Survivors Conference is happening this fall in San Francisco on October 19-21. The conference will be an invaluable resource for those affected by the disease, and features many experts on the disease among its panel of speakers. The sessions won't just ...

    August 31st, 2007 | No comments yet

      Cancer war
      All about cancer!